Skip to content
Screener

NeoGenomics NEO Finite-Lived Intangible Assets, Accumulated Amortization

Finite-Lived Intangible Assets, Accumulated Amortization at other companies

Natera, Inc. logo
Natera, Inc.NTRA
$19.17M
Myriad Genetics logo
Myriad GeneticsMYGN
Labcorp Holdings logo
Labcorp HoldingsLH
Guardant Health logo
Guardant HealthGH
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
GeneDx Holdings logo
GeneDx HoldingsWGS

Other financials

Income statement

See full
Revenue$201.7M+11.2%
Gross profit$91.9M+18.9%
Operating income-$9.8M+79.5%
Net income$2.2M+105%
EPS (diluted)$0.02+106%

Balance sheet

See full
Cash & equivalents$145.5M-5.9%
Total debt$448.4M+534%
Total equity$785.7M-8.0%
Total assets$1.4B-3.0%

Cash flow

See full
Operating cash flow$20.0M-1.8%
CapEx$8.2M+30.0%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$2.13B+183%
Enterprise value$2.43B+264%
P/S2.8×+1.7×

Profitability

See full
Gross margin43.9%0.0pp
Operating margin-8.9%-2.8pp
Net margin-6.8%-2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-6.3%-2.0pp
Debt / equity0.6×+0.5×
Current ratio3.6×-0.3×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001077183-26-000059
Line itemAmortization Period (years)June 30, 2026 / CostJune 30, 2026 / Accumulated AmortizationJune 30, 2026 / Net
Customer Relationships7 - 15$144,301$90,471$53,830
Developed Technology10 - 15276,82592,942183,883
Trademarks1530,26110,15920,102
Trademark - Indefinite lived13,44713,447
Total$464,834$193,572$271,262

Item 1. Financial Statements (unaudited)

FAQ

What is NeoGenomics's finite-lived intangible assets, accumulated amortization?
NeoGenomics (NEO) reported finite-lived intangible assets, accumulated amortization of $193.57M in Q2 2026.
How has NeoGenomics's finite-lived intangible assets, accumulated amortization changed year-over-year?
NeoGenomics's finite-lived intangible assets, accumulated amortization increased by 18.7% year-over-year, from $163.04M to $193.57M.

Ask your AI about NeoGenomics's finite-lived intangible assets, accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude